Although the aetiology of endogenous uveitis is largely unknown, for many years various viruses have been implicated in its pathogenesis. ' Recently not only have viruses been isolated from the eye2 but electron microscopy has revealed virus particles in uveal tissue.5 Hepatitis B virus (HBV) is generally associated with acute hepatitis, which in some cases becomes chronic and may lead to postnecrotic cirrhosis and possibly hepatocellular carcinoma. But some persons after infection with HBV remain asymptomatic, with little or no liver damage. This is associated with transient appearance in the blood of virus-derived surface antigen (HBsAg), previously known as Australia antigen, leading to the development of protective antibodies. The antigen may persist in certain individuals for prolonged periods with minimal immune response, leading to a chronic carrier state.
Recently it has become recognised that HBV may be responsible for a variety of ill understood systemic diseases with vasculitis as a common denominator. Persistent production of surface antigen (HBsAg) and antigen derived from the virus core (HBcAg) and consequent development of specific antibodies lead to the formation of circulating immune complexes that activate inflammatory components of complement producing tissue damage primarily in the vascular system.6 It is not surprising therefore that HBV has been implicated in the development of certain forms of glomerulonephritis,"8 polyarteritis nodosa,910 polymyalgia rheumatica," infantile papular acrodermatitis,'2 essential mixed cryoglobulinaemia,"3 and arthralgia.14 It is logical therefore to suspect that HBV-associated immune complexes may initiate intraocular inflammation, particularly uveitis.
A study from Switzerland'" indicates that a statistically significant proportion of patients (13%) with uveitis contain virus-derived surface antigen (HBsAg) (27 nm ) of the double shelled particle (45 nm) known as the Dane22 particle. The third type of particle (22 nm) contains no DNA and appears to consist of excess coat material. The HBsAg is on the surface of the latter 2 types of particles. The Dane particle contains the DNA and is presumed to be the infective virus. The HBeAg is located on the Dane particle, probably on the surface, but is also free in the serum. For all practical purposes the detection of HBsAg in a patient's blood is tantamount to declaring this blood infective-that is, that it contains HBV.
Infection with HBV is a result of transfer of virus from an infected to a susceptible individual. The infection may be transmitted by accidental inoculation of minute amounts of blood or fluid contaminated with blood such as may occur during medical, surgical, and dental procedures, immunisation with inadequately sterilised syringes and needles, intravenous and percutaneous drug abuse, tattooing, ear and nose piercing, acupuncture, laboratory accidents, and accidental inoculation with razors and similar sharp objects that have been contaminated with blood. There is much evidence of the transmission of hepatitis B by intimate contact and by the sexual route. The sexually promiscuous, particularly male homosexuals, are at very high risk. Since HBsAg is found not only in blood but also in various body fluids such as saliva, genital secretions, and breast milk it is not surprising that these have been implicated as vehicles of transmission of infection. Recently it has been demonstrated in tears from about half of seropositive individuals,23 which raises Status ofhepatitis B virus in the aetiology ofuveitis in Great Britain the possibility of cross-infection through conjunctival-corneal route via tonometers24 and contact lenses.25 It is also possible that the virus finds its way into other ocular fluids such as aqueous humour, thus challenging the uvea directly.
The presence of HBsAg in blood and body secretions in apparently healthy individuals is related to a carrier state, which may be defined as the persistence of the antigen in the circulation for longer than 6 months. In Northern Europe including Great Britain, North America and Australia chronic carriers number 0-2% or less of the general population although a much higher frequency may be found in selected groups such as doctors, dentists and nurses. A higher frequency (i.e. 5%) is observed in Central and Eastern Europe while in some parts of Africa, Asia,26 Pacific region as many as 10-20% or more of the apparently healthy population may be carriers. 27 In the present study we found that 2% (i.e. 4 out of the 200 patients tested) had circulating HBsAg. This is 10 times higher than one would expect from the, indigenous control population but could be regarded normal for several other countries. All 4 patients had acute anterior uveitis, with equal sex distribution. Since we did not perform a longitudinal study, it is not known if these patients represent a chronic carrier state or if blood was collected during the prodromal phase of acute hepatitis. The Swiss study"5 reported that 13% of patients with uveitis were HBsAg positive, this is a much higher figure than obtained in the present investigation. The discrepancy could be either due to geographical differences or to different methods used to detect HBsAg. They used solidphase radioimmunoassay (Abbott), whereas direct passive haemagglutination was used in our study. It is well accepted, however, that the technique we used is highly sensitive and is superior to immunodiffusion in agar, counterimmunoelectrophoresis, and complement fixation; it is only marginally less sensitive than radioimmunoassay.
In conclusion HBV appears to play an important role in the pathogenesis of vasculitis in various systemic diseases,6 and it is conceivable that it may contribute in a few instances to the aetiology of uveitis through an immune complex mediated reaction, We do not feel, however, that HBV plays an important part in the pathogenesis of uveitis in this country.
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